Kuang M - Search Results

1

Comparison of Hepatic Resection with Percutaneous Ablation for Hepatocellular Carcinoma in the Caudate Lobe Within Milan Criteria.

Xie W, Tan J, Li B, Chen S, Liu B, Shen J, Fu S, Kuang M, Sun K, Zeng X. Xie W, et al. Among authors: kuang m. J Gastrointest Surg. 2022 Feb;26(2):323-332. doi: 10.1007/s11605-021-05111-0. Epub 2021 Sep 7. J Gastrointest Surg. 2022. PMID: 34494218

2

[Hepatic arterial infusion of 32P-radionuclide microspheres for radiation therapy of hepatocellular carcinoma].

Liang L, Huang J, Yin X, Lu M, Rao G, Ren Z, Li D, Kuang M. Liang L, et al. Among authors: kuang m. Zhonghua Wai Ke Za Zhi. 1999 Dec;37(12):743-6. Zhonghua Wai Ke Za Zhi. 1999. PMID: 11829942 Chinese.

3

Phase II randomized trial of autologous formalin-fixed tumor vaccine for postsurgical recurrence of hepatocellular carcinoma.

Kuang M, Peng BG, Lu MD, Liang LJ, Huang JF, He Q, Hua YP, Totsuka S, Liu SQ, Leong KW, Ohno T. Kuang M, et al. Clin Cancer Res. 2004 Mar 1;10(5):1574-9. doi: 10.1158/1078-0432.ccr-03-0071. Clin Cancer Res. 2004. PMID: 15014006 Clinical Trial.

4

Tumor vaccine against recurrence of hepatocellular carcinoma.

Peng BG, Liang LJ, He Q, Kuang M, Lia JM, Lu MD, Huang JF. Peng BG, et al. Among authors: kuang m. World J Gastroenterol. 2005 Feb 7;11(5):700-4. doi: 10.3748/wjg.v11.i5.700. World J Gastroenterol. 2005. PMID: 15655825 Free PMC article. Clinical Trial.

5

Systemic chemo-immunotherapy for advanced-stage hepatocellular carcinoma.

Yin XY, Lü MD, Liang LJ, Lai JM, Li DM, Kuang M. Yin XY, et al. Among authors: kuang m. World J Gastroenterol. 2005 Apr 28;11(16):2526-9. doi: 10.3748/wjg.v11.i16.2526. World J Gastroenterol. 2005. PMID: 15832431 Free PMC article. Clinical Trial.

6

Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy.

Lu MD, Yin XY, Xie XY, Xu HX, Xu ZF, Liu GJ, Kuang M, Zheng YL. Lu MD, et al. Among authors: kuang m. Br J Surg. 2005 Nov;92(11):1393-8. doi: 10.1002/bjs.5102. Br J Surg. 2005. PMID: 16044409

7

Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.

Xu HX, Lu MD, Xie XY, Yin XY, Kuang M, Chen JW, Xu ZF, Liu GJ. Xu HX, et al. Among authors: kuang m. Clin Radiol. 2005 Sep;60(9):1018-25. doi: 10.1016/j.crad.2005.04.009. Clin Radiol. 2005. PMID: 16124984

8

Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study.

Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, Xu ZF, Liu GJ, Zheng YL. Lu MD, et al. Among authors: kuang m. J Gastroenterol. 2005 Nov;40(11):1054-60. doi: 10.1007/s00535-005-1671-3. J Gastroenterol. 2005. PMID: 16322950

9

[Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].

Lü MD, Kuang M, Liang LJ, Xie XY, Peng BG, Liu GJ, Li DM, Lai JM, Li SQ. Lü MD, et al. Among authors: kuang m. Zhonghua Yi Xue Za Zhi. 2006 Mar 28;86(12):801-5. Zhonghua Yi Xue Za Zhi. 2006. PMID: 16681964 Clinical Trial. Chinese.

10

Autologous tumor vaccine lowering postsurgical recurrent rate of hepatocellular carcinoma.

Peng B, Liang L, Chen Z, He Q, Kuang M, Zhou F, Lu M, Huang J. Peng B, et al. Among authors: kuang m. Hepatogastroenterology. 2006 May-Jun;53(69):409-14. Hepatogastroenterology. 2006. PMID: 16795983 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

723 results

Search Page

Filters